These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4393594)

  • 1. Block of adrenergic beta-receptors by propranolol in the treatment of thyrotoxicosis.
    Felt V
    Rev Czech Med; 1970; 16(3):140-4. PubMed ID: 4393594
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of beta-blocking agents in hyperthyroidism.
    Földes J; Bános C; Borvendég J; Gyertyánfy G
    Acta Med Acad Sci Hung; 1979; 36(4):375-80. PubMed ID: 45285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Propranolol treatment of thyrotoxicosis].
    Karlberg B
    Lakartidningen; 1970 Dec; 67(50):5917-22. PubMed ID: 4395268
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of propranolol in thyrotoxicosis.
    Horowitz W; Canary JJ
    N Engl J Med; 1971 Feb; 284(6):333-4. PubMed ID: 4395388
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of adrenergic beta blockaders in thyrotoxicosis and hypothyroidism].
    Feldstein CA; Duhart JE; Henry EC; Degrossi OJ
    Prensa Med Argent; 1970 May; 57(9):454-8. PubMed ID: 4397115
    [No Abstract]   [Full Text] [Related]  

  • 6. [The beta-blocking drugs in hyperthyroidism. I. Effects on the cardiovascular syndrome].
    Ghidini O; Bellotti G; De Gregori ME; Salazzari G; Giardina F
    Minerva Med; 1971 Mar; 62(26):1363-73. PubMed ID: 4396565
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of thyrotoxicosis with beta-blocking agents].
    Dogliotti L; Fonzo D; Lauro R; De Martinis C
    Minerva Med; 1971 Oct; 62(77):3679-84. PubMed ID: 4398567
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative influence of propranolol and verapamil on glycemic control and histamine sensitivity associated with L-thyroxine-induced hyperthyroidism - an experimental study.
    Bhatt PA; Makwana D
    Fundam Clin Pharmacol; 2008 Feb; 22(1):53-9. PubMed ID: 18251722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Hyperthyroidism.
    Obstet Gynecol; 1975 Jul; 46(1):112-4. PubMed ID: 239370
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of beta receptor blockaders on hyperthyroidism].
    Földes J; Bános C; Borvendég J; Gyertyánfy G
    Orv Hetil; 1979 May; 120(18):1080-2. PubMed ID: 35773
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of adrenergic blockade by trimepranol and propranolol on protein iodine and the severity of thyrotoxicosis].
    Felt V; Vána S; Zamrazil V
    Cas Lek Cesk; 1971 Jun; 110(25):595-7. PubMed ID: 4103498
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of thyrotoxicosis. With special reference to the use of beta blockaders].
    Solem JH
    Tidsskr Nor Laegeforen; 1980 Nov; 100(33):1975-9. PubMed ID: 6109381
    [No Abstract]   [Full Text] [Related]  

  • 13. [Beta-adrenergic blocking therapy in thyrotoxicosis].
    Erikssen J
    Tidsskr Nor Laegeforen; 1970 Jun; 90(11):1206-10. PubMed ID: 4393742
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of propranolol, atenolol and metoprolol on the serum levels of thyroxin (T4) and triiodothyronine (T3).
    Shikara MM; Maniar R; Steier W; Rao S; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():127. PubMed ID: 14699907
    [No Abstract]   [Full Text] [Related]  

  • 15. Sympathetic beta adrenergic blockade in the preoperative treatment of hyperthyroidism.
    Brody AG; Dibble R
    Med Ann Dist Columbia; 1974 Feb; 43(2):72-4. PubMed ID: 4149916
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blocking of adrenergic beta receptors with propranolol in the treatment of thyrotoxicosis].
    Felt V
    Cas Lek Cesk; 1969 Sep; 108(38):1124-7. PubMed ID: 5810135
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the effect of beta-adrenergic receptor blocking agents in thyroitoxic cardiopathies in the aged. (Statistical study)].
    Pasoli CA; Forte PL; Luzi-Crivellini A; Pasoli A; Girelli Bruni E; Bellini P
    Fracastoro; 1970; 63(1):18-32. PubMed ID: 4394523
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Adrenergic-blocking drugs in hyperthyroidism.
    Distiller LA; Joffe BI; Seftel HC
    Ann Intern Med; 1973 Dec; 79(6):899-900. PubMed ID: 4148614
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
    Shikara MM; Polena S; Solinas A; Sanghvi K; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():125-6. PubMed ID: 14699906
    [No Abstract]   [Full Text] [Related]  

  • 20. [Propranolol treatment in thyrotoxicosis].
    Cullhed I; Parrow A
    Lakartidningen; 1969 Sep; 66(39):3961-5. PubMed ID: 5384300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.